Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Ondansetron (8 mg) Tablet
Dosage Form : Tablet
Packaging Type : Alu Alu
Packaging : 10*10
Price : ₹95.13/-
LAPANIB 250 Tablet (Lapatinib 250 mg) is a highly specialized, oral, targeted cancer medicine classified as a Dual Tyrosine Kinase Inhibitor (TKI). It is a critical treatment component for patients diagnosed with HER2-positive advanced or metastatic breast cancer.
Mechanism and Impact:Lapatinib works by selectively and reversibly binding to the intracellular domain of two key receptors: Human Epidermal Growth Factor Receptor 2 (HER2) and Epidermal Growth Factor Receptor (EGFR). By competitively blocking the signaling pathways, Lapatinib effectively halts the uncontrolled tumor cell growth. This dual-action mechanism is particularly valuable in treating cancers that have progressed following treatment with other HER2-targeted agents.
Key Therapeutic Uses (Combination Therapy):
With Capecitabine: For patients whose cancer has progressed after prior therapy including an anthracycline, a taxane, and trastuzumab.
With Letrozole: For postmenopausal women with hormone receptor-positive and HER2-positive metastatic breast cancer.
We offer an exclusive PCD Pharma Franchise opportunity for LAPANIB 250, providing partners with monopoly rights in this specialized, high-demand segment of targeted breast cancer therapeutics.
Common side effects may include headache, constipation, dry mouth, and dizziness. Rarely, serious side effects such as allergic reactions, blurred vision, or irregular heartbeat may occur.
Indicated for the prevention and treatment of nausea and vomiting caused by chemotherapy, radiotherapy, or surgery. To be used under medical guidance.
Use under the supervision of a healthcare professional. Inform your doctor about any existing heart, liver, or gastrointestinal conditions. Do not exceed the prescribed dosage.
Store below 25°C in a cool, dry place away from direct light. Keep out of reach of children. Dispose of unused medicine as per medical advice.
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Rosuvastatin 20mg + Clopidogrel 75mg Tablet
Composition : Prazosin (2.5mg) Sustained Release Tablet
Composition : Prazosin (5 mg) Sustained Release
Composition : Metoprolol Succinate 100mg PR Tablet
Composition : Metoprolol 12.5 XL Tablet
Composition : Metoprolol Succinate (25mg) ER Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation